Processing

Please wait...

Settings

Settings

1. WO2017130130 - NUTRITIONAL SUPPLEMENT FOR MAINTAINING THE STATE OF HEALTH OF THE EYE

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

1. A composition comprising

(a) dry extract of Centella asiatica

and

(b) at least one nutrient selected from (bl) lutein, (b2) resveratrol, and (b3) dry extract of Vaccinium myrtillus.

2. The composition according to claim 1, comprising

(a) dry extract of Centella asiatica, 5 to 15 mg

and

(bl) lutein, 5 to 15 mg, or (b2) resveratrol, 20 to 30 mg, or (b3) dry extract of Vaccinium myrtillus, 20 to 30 mg.

3. The composition according to claim 1 or 2, comprising

(a) dry extract of Centella asiatica, preferably between 5 and 15 mg,

(bl) lutein, preferably between 5 and 15 mg, and

(b2) resveratrol, preferably between 20 and 30 mg, or (b3) dry extract of Vaccinium myrtillus, preferably between 20 and 30 mg,

or

(a) dry extract of Centella asiatica, preferably between 5 and 15 mg,

(b2) resveratrol, preferably between 20 and 30 mg, and

(bl) lutein, preferably between 5 and 15 mg, or (b3) dry extract of Vaccinium myrtillus, preferably between 20 and 30 mg,

or

(a) dry extract of Centella asiatica, preferably between 5 and 15 mg,

(b3) dry extract of Vaccinium myrtillus, preferably between 20 and 30 mg, and

(bl) lutein, preferably between 5 and 15 mg, or (b2) resveratrol, preferably between 20 and 30 mg.

4. The composition according to any one of the preceding claims, comprising

(a) dry extract of Centella asiatica, and/or (bl) lutein in a quantity, independently of each other, of less than 13 mg, more preferably less than 1 1 mg; greater than 7 mg, more preferably greater than 9 mg; preferably comprised between 7 and 13 mg

and/or

(b2) resveratrol and/or dry extract of Vaccinium myrtillus, in a quantity independently of each other of less than 28 mg, more preferably less than 26 mg; greater than 22 mg, more preferably greater than 24 mg; preferably comprised between 22 and 28 mg.

5. The composition according to any one of the preceding claims, comprising

(a) dry extract of Centella asiatica, between 5 and 15 mg,

(bl) lutein, between 5 and 15 mg,

(b2) resveratrol, between 20 and 30 mg, and

(b3) dry extract of Vaccinium myrtillus, between 20 and 30 mg.

6. The composition according to any one of the preceding claims, in the form of a tablet, capsule of soft gelatin or capsule of hard gelatin.

7. A capsule comprising the composition as defined in any one of claims 1 to 5.

8. The composition is defined in any one of claims 1 to 5 or the capsule as defined in claim 7, for use in maintaining the state of health of the eye, and/or in the prevention and/or treatment of ocular diseases associated with age-related macular degeneration (AMD), diabetic retinopathy (DRP), tapetoretinal degeneration, hypertensive retinopathy, central serous retinopathy, glaucoma, cataract.

9. The composition or capsule according to claim 8, for use in maintaining the state of health of the eye.

10. The composition or capsule according to claim 8, for use in the prevention and/or treatment of ocular diseases associated with age-related macular degeneration (AMD), diabetic retinopathy (DRP), central serous retinopathy, glaucoma, cataract.